Skip to main content
Premium Trial:

Request an Annual Quote

MedGenome KaryoSeq

MedGenome has launched KaryoSeq, a clinical next-gen sequencing test for the detection of chromosomal abnormalities including trisomies 13, 18, and 21 and microdeletions larger than 2 Mb. The test, which is performed in India and available in this as well as several other countries, is recommended for individuals with a suspected or confirmed genetic disorder and those at increased risk of carrying a chromosomal abnormality. It can be used in both the prenatal and postnatal setting but its major application is anticipated to be in the prenatal area, according to the company.